News
	
	
	
		Clinical Significance of Smaller Gaps Between Strengths of Levothyroxine Preparations in the Treatment of Hypothyroidism
Many levothyroxine preparations have relatively large intervals between doses (25 µg, 50 µg, and 75 µg), creating obstacles for some patients to achieve an optimal maintenance dose. The availability of tablets that allow for dosing in between these values facilitates precise and effective titration of levothyroxine doses, especially at the lower end of the spectrum.
			Generic Substitution of Levothyroxine in Practice
					The active ingredient levothyroxine is found in a significant number of medicinal products (MP) in…
			
	
			Options for Systemic Therapy of Advanced Stage Small Cell Lung Cancer
					Small cell lung cancer (SCLC) is the most aggressive type of lung tumor. Although it responds well…
			
	
			Current Sequence of Treatment for Metastatic HER2+ Breast Cancer
					In September 2023, experts from Miami Cancer Institute published their consensus statement on the…
			
	
			Artificial Intelligence and Deep Learning as the Future of Glaucoma Diagnosis
					Glaucoma represents a group of eye diseases characterized by changes to the optic nerve. It is the…
			
	
			MUDr. Jana Zárubová: Experiences with buccal midazolam in real practice are positive and we can significantly improve patients' quality of life
					Recently, it has emerged as an alternative to traditionally rectally administered diazepam for…
			
	
			IEC 2023: Key Challenges for Epilepsy Patients Include Status Epilepticus and Anxiety Management
					Why is anxiety a significant issue for epilepsy patients? What do current insights say about the…
			
	
			Ocrelizumab in the Treatment of Multiple Sclerosis – 10-Year Data
					Multiple sclerosis (MS) is a lifelong disease with a high risk of permanent disability. Current…
			
	
			Long-term Efficacy and Safety of Mavacamten in the Treatment of Obstructive HCM
					Interim results of the MAVA-LTE study provide the latest data on the long-term safety and efficacy…
			
	
			Mavacamten in the Treatment of HCM in Patients Referred for Septal Reduction
					Extended 56-week follow-up of patients with hypertrophic cardiomyopathy (HCM) resistant to current…
			
	
Popular this week
- Vaccination Against Hepatitis A Has Been Most Neglected Among People With Liver Disease
 - How Is Adolescent Self-Harm Related to Addiction?
 - AI Searches for New Antibiotics in Animal Venoms
 - What Are the Links Between Gambling, Depression, and Feelings of Escape During Play?
 - AI-Powered Phishing: A Growing Threat to Healthcare